“Digoxin toxicity”的搜索结果，显示 311-320 项，共有 11963 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

4. 血液科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... toxicity of on-time and serial administration of MV-s-NAP in patients with metastic breast cancer. A Study To Evaluate Immune-related Biomarkers For ...

6. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

7. 肾病和高血压- 临床试验- 妙佑医疗国际

   Rochester, Minn. The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients ...

8. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...